Reviews in Endocrine & Metabolic Disorders
Overview
Reviews in Endocrine & Metabolic Disorders is a scholarly journal that provides comprehensive and up-to-date reviews on various aspects of endocrine and metabolic disorders. It covers topics such as diabetes, thyroid disorders, obesity, and hormonal imbalances, offering valuable insights into the latest research, diagnostic approaches, and therapeutic interventions. This journal serves as a valuable resource for clinicians, researchers, and healthcare professionals seeking to enhance their understanding and management of endocrine and metabolic disorders.
Details
Details
Abbr.
Rev Endocr Metab Disord
Publisher
Springer
Start
2000
End
Continuing
Frequency
Quarterly
p-ISSN
1389-9155
e-ISSN
1573-2606
Country
Germany
Language
English
Specialty
Endocrinology
Metrics
Metrics
h-index / Ranks: 3170
99
SJR / Ranks: 1133
2075
CiteScore / Ranks: 804
13.00
JIF / Ranks: 656
8.2
Recent Articles
1.
Demarchis L, Chiloiro S, Giampietro A, De Marinis L, Bianchi A, Fleseriu M, et al.
Rev Endocr Metab Disord
. 2025 Mar;
PMID: 40088375
Acromegaly is a rare condition, and often diagnosis is delayed by several years, for most patients. Acromegaly is characterized by short and long-term respiratory, cardiovascular and metabolic comorbidities, with possible...
2.
Dieguez C, Lopez M, Casanueva F
Rev Endocr Metab Disord
. 2025 Mar;
PMID: 40087221
No abstract available.
3.
Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J
Rev Endocr Metab Disord
. 2025 Mar;
PMID: 40064750
Obesity and type-2 diabetes mellitus (T2DM) are interrelated metabolic disorders primarily driven by overnutrition and physical inactivity, which oftentimes entails a transition from obesity to T2DM. Compromised musculoskeletal health consistently...
4.
Pejon T, Messias L, de Oliveira Nascimento R, Bertolucci V, Ninomiya A, Beck W
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 40009141
Purpose: Hypoestrogenism is associated with loss of bone mass and strength. Melatonin has become a strategy due to its actions on bone tissue. This review summarizes the available data on...
5.
Al-Awadi A, Gray S, Al-Ozairi E
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39998784
People with type 2 diabetes (T2D) have a 2-3-time higher risk of developing sarcopenia, a musculoskeletal disease marked by a progressive loss of skeletal muscle mass and strength, compared to...
6.
Hacioglu A, Tekiner H, Altinoz M, Ekinci G, Bonneville J, Yaltirik K, et al.
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39939491
A Rathke's cleft cyst (RCC) is a remnant of the embryologic Rathke's pouch and a common pituitary lesion. A true RCC is lined with ciliated cuboidal or columnar epithelia with...
7.
Halmos G, Szabo Z, Dobos N, Juhasz E, Schally A
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39934495
The hypothalamic polypeptide growth hormone-releasing hormone (GHRH) stimulates the secretion of growth hormone (GH) from the pituitary through binding and activation of the pituitary type of GHRH receptor (GHRH-R), which...
8.
Stumpf M, Cercato C, de Melo M, Mancini M
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39920515
The global prevalence of obesity among elderly patients continues to rise. Despite the availability of new antiobesity medications, bariatric surgery remains an effective treatment option for carefully selected candidates. However,...
9.
Carlos D, Dieguez C, Miguel L, Lopez M, Casanueva F, Felipe C
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39913072
Despite initial discovery in pancreatic tumors, GHRH is a 44-amino acid peptide primarily expressed in the hypothalamus. Recent RNA sequencing clarifies GHRH expression: predominantly hypothalamic in humans, with some basal...
10.
Sarmento-Cabral A, Fuentes-Fayos A, Ordonez F, Leon-Gonzalez A, Martinez-Fuentes A, Gahete M, et al.
Rev Endocr Metab Disord
. 2025 Feb;
PMID: 39910005
The prostate gland is an endocrine-sensitive organ responding to multiple stimuli. Its development and function are regulated by multiple hormones (i.e. steroids such as androgens, estrogens and glucocorticoids) but also...